Russell Frank Company’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$17M Buy
294,050
+234,593
+395% +$13.3M 0.03% 659
2015
Q4
$3.23M Sell
59,457
-3,410
-5% -$192K 0.01% 1530
2015
Q3
$3.2M Buy
62,867
+964
+2% +$51.9K 0.01% 1568
2015
Q2
$3.49M Buy
61,903
+16,235
+36% +$1.02M 0.01% 1655
2015
Q1
$3.28M Sell
45,668
-2,572
-5% -$167K 0.01% 1490
2014
Q4
$2.62M Buy
48,240
+3,392
+8% +$177K ﹤0.01% 1631
2014
Q3
$2.21M Sell
44,848
-241
-0.5% -$12.3K ﹤0.01% 1685
2014
Q2
$2.33M Buy
45,089
+25,800
+134% +$1.28M ﹤0.01% 1673
2014
Q1
$943K Sell
19,289
-2,609
-12% -$117K ﹤0.01% 2110
2013
Q4
$1.03M Sell
21,898
-98,051
-82% -$4.96M ﹤0.01% 2055
2013
Q3
$6.34M Sell
119,949
-41,826
-26% -$2.03M 0.01% 1162
2013
Q2
$7.3M Buy
+161,775
New +$7.68M 0.01% 1010

Other funds holding RMD

Russell Frank Company's RMD Position: Q1 2016 in Review

Russell Frank Company increased its ResMed (RMD) stake by 395% in Q1 2016, buying an estimated $13.3M and bringing the position to 294,050 shares worth $17M. The position accounts for 0.03% of the portfolio, ranked #659.

Russell Frank Company first reported a position in RMD in Q2 2013 and has held it in 12 quarters since. 374 funds tracked by Wall St. Rank hold RMD as of Q1 2016.

  • Russell Frank Company held 294,050 shares of ResMed worth $17M as of Q1 2016.
  • Russell Frank Company bought 234,593 ResMed shares in Q1 2016, an estimated $13.3M.
  • ResMed made up 0.03% of Russell Frank Company's portfolio in Q1 2016, its #659 holding.
  • Russell Frank Company first reported a position in ResMed in Q2 2013 and has held it in 12 quarters since.
  • 374 funds tracked by Wall St. Rank held ResMed as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.